Evaluation of the sensitivities of six triple-negative breast cancer (TNBC) cell lines to 23 different PI3K/AKT/mTOR inhibitors or to a MEK inhibitor (trametinib). Dataset 1 of 2: GR values. - Dataset (ID:20364)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell line | Drug name | Experimental replicate | Timepoint | Drug concentration | Live cell count | Average live cell count, DMSO control | Average live cell count (time = 0) | Log10(drug concentration) | GR value | Relative cell count (treatment versus DMSO) | Cell doublings (DMSO control) | Experiment name |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HCC1806 | AZD-6482 | 3 | 72 | 0.1 | 12053.8 | 11709.8 | 1273.3 | -1.0 | 1.020 | 1.030 | 3.201 | HCC1806 AZD6482 0 3 72 |
| HCC1806 | AZD-6482 | 1 | 72 | 0.1 | 12053.8 | 11709.8 | 1742.8 | -1.0 | 1.020 | 1.030 | 2.748 | HCC1806 AZD6482 0 1 72 |
| HCC1806 | AZD-6482 | 2 | 72 | 0.1 | 12053.8 | 11709.8 | 1643.3 | -1.0 | 1.020 | 1.030 | 2.833 | HCC1806 AZD6482 0 2 72 |
| HCC1806 | XL147 | 3 | 72 | 3.2 | 12161.5 | 11581.0 | 1273.3 | 0.505 | 1.030 | 1.050 | 3.185 | HCC1806 XL147 0 3 72 |
| HCC1806 | XL147 | 1 | 72 | 3.2 | 12161.5 | 11581.0 | 1742.8 | 0.505 | 1.040 | 1.050 | 2.732 | HCC1806 XL147 0 1 72 |
| HCC1806 | XL147 | 2 | 72 | 3.2 | 12161.5 | 11581.0 | 1643.3 | 0.505 | 1.040 | 1.050 | 2.817 | HCC1806 XL147 0 2 72 |